Introduction
Gadd45a, whose transcriptional upregulation by ionizing radiation (IR) is dependent on wild-type (wt) p53, has been suggested to have many cellular functions including DNA repair, chromatin remodeling and execution of certain cell cycle checkpoints (for a review see Hildesheim and Fornace 1 ). Cells deficient for Gadd45a exhibit hallmarks of genomic instability including aneuploidy, centrosome abnormalities and gene amplification, as well as defects in growth control. 2, 3 These are also characteristics of cells lacking functional p53, 4 suggesting that Gadd45a may be a downstream effector for p53-mediated responses. In addition, mice lacking Gadd45a exhibit a low frequency of exencephaly similar to that of p53-deficient mice. 2, 5 IR-induced tumorigenesis is more rapid in Gadd45aÀ/À mice than in wt mice, but not as rapid as that in p53-deficient mice. 2, 6 These similar animal phenotypes suggest a link between p53 function and Gadd45a function. In addition, the recent finding that Gadd45a can contribute to p53 activation through p38 signaling 7, 8 implicates p53-mediated mechanisms in phenotypes observed in Gadd45aÀ/À mice and cells. However, p53À/À mice exhibit rapid spontaneous tumorigenesis, 9 which is absent in Gadd45aÀ/À mice, and p53À/À mice do not exhibit thymus enlargement typical of Gadd45aÀ/À mice, indicating that there is incomplete overlap of phenotypes. In order to determine nonoverlapping functions of Gadd45a and p53, mice lacking both genes were generated. While p53À/À mice develop several types of malignancies, nearly all Gadd45aÀ/Àp53À/À mice developed lymphoma. Most were classified as lymphoblastic lymphoma (LBL) and presented with large thymic masses. Gadd45aÀ/À mice were also bred into the leukemia/lymphoma-prone AKR strain, resulting in decreased latency and increased incidence of LBL. It is proposed that Gadd45a is a modifier allele for LBL in mice, whereby deletion leads to this disease in susceptible mice. Although deletions and mutations of Gadd45a were not found in biopsies from related human malignancies, epigenetic changes in the expression of Gadd45a could not be excluded.
Methods
Gadd45aÀ/À and p53À/À mice have been described previously. 2, 9 Two Gadd45aÀ/À females were mated with one p53 heterozygote. All Gadd45aÀ/Àp53À/À and p53À/À animals in this study were derived from these original founders so that both genotypes had the same mixed genetic background (SJL, 129 and C57BL6). Gadd45aÀ/À mice were bred with AKR mice and the F1 bred to generate Gadd45aÀ/À/AKR, Gadd45a þ /À/AKR and wt/AKR for spontaneous carcinogenesis. Only mice with lymphoma in the thymus, spleen or lymph nodes were included in the analysis of lymphoma in this model. Animals dying or moribund due to other causes, presumably leukemia, were included initially but were censored at the time of death. Mice were housed in Plexiglas cages and given autoclaved NIH 31 diet and water ad libidum. NIH is an AALAC accredited animal facility and all experiments were carried out under an approved NIH animal study protocol.
For tumorigenesis studies, animals exhibiting obvious tumors or who were moribund, cachectic or nonresponsive were euthanized by CO 2 asphyxiation. The spleen, thymus, lymph nodes and any tumors or abnormal tissues were taken for histopathological analysis. Thymic masses were noted at necropsy, filled most of the thoracic space and did not include cases where the thymus was merely enlarged with normal appearance. Tissues were fixed in 10% neutral-buffered formalin, processed to paraffin, sectioned at 5 mm and stained with hematoxylin and eosin. Tumors were diagnosed by a board certified veterinary pathologist. Data were analyzed with Prism software (GraphPad Software Inc.), using log-rank test for survival and w 2 test for LBL and thymic mass incidence. For determination of tumor cell type, cells were disbursed into PBS and stained with antibodies to CD3 and CD20 to determine whether they were B or T cell, and with CD4 and CD8 to determine T-cell type. Secondary antibodies were conjugated to FITC or PE, and cells were analyzed by FACS.
Gadd45a exons were amplified from DNA isolated from T-cell non-Hodgkin's lymphoma (T-NHL) biopsies, normal tissue from these same patients and from bone marrow of T-cell acute lymphoblastic leukemia (T-ALL) and B-cell acute lymphoblastic leukemia (B-ALL) patients. Primers for each exon were in the flanking introns or in flanking nontranslated sequences (for exons 1-4) ( Table 1 ). ALL samples analyzed were obtained from the ALL cell bank of the Children's Hospital, Denver, CO, USA under an IRB approved protocol. PCR products were purified from agarose gels and sequenced using the same primers used for the PCR.
Results
In crosses between mice heterozygous for both Gadd45a and p53, fewer Gadd45aÀ/Àp53À/À pups were obtained than expected by Mendelian genetics, and at weaning time (21 days of age), most double null animals were male (data not shown). Both male and female Gadd45aÀ/Àp53À/À animals were indistinguishable from their littermates and were fertile. Developmental effects of deletion of both Gadd45a and p53 will be published elsewhere.
Gadd45aÀ/Àp53À/À and p53À/À mice were monitored for tumors up to age 32 weeks. Tumor latency for Gadd45aÀ/À p53À/À mice was similar to that observed for p53À/À mice ( Figure 1 ). The cohort consisted of 23 Gadd45aÀ/Àp53À/À mice (20 males and three females) and 20 p53À/À mice (13 males and seven females). Tumor findings for these mice are shown in Table 2 and Figure 2 . In all, 87% of Gadd45aÀ/À p53À/À animals developed LBL, while only 40% of p53À/À animals developed this tumor type (P ¼ 0.0008). Total lymphoma incidence was 96% for Gadd45aÀ/Àp53À/À and 45% for p53À/À mice (Po0.0001). In total, 70% (16/23) of Gadd45aÀ/Àp53À/À mice presented with large thymic (mediastinal) masses, often filling the entire thoracic cavity, and these mice were typically identified prior to necropsy by labored breathing. Six of 20 p53À/À mice presented with large thymic masses, which was significantly fewer than the 16/23 incidence in Gadd45aÀ/Àp53À/À mice (P ¼ 0.0088). However, the percent of LBL presenting with thymic masses was comparable between p53À/À and Gadd45aÀ/Àp53À/À mice (75 and 80%, respectively). Average age at detection of lymphoma was 20 and 21 weeks for Gadd45aÀ/Àp53À/À and p53À/À, respectively. Four thymic masses that were analyzed from Gadd45aÀ/À p53À/À mice were found to consist of CD4 À CD8 À T cells (data not shown). This is consistent with the tumors originating from immature T cells. In contrast to lymphomas, p53À/À and Gadd45aÀ/Àp53À/À animals had similar frequencies of hemangiosarcoma, the most frequent type of sarcoma seen for both groups. Although there were several other sarcomas in the p53À/À cohort, the frequency of all sarcomas between strains was not significant (P ¼ 0.0972).
Since the predominant tumor type in IR-induced Gadd45aÀ/À carcinogenesis was lymphoma, and Gadd45aÀ/Àp53À/À mice had such a high incidence of lymphoma, we hypothesized that Table 1 PCR
CTAATTTGTCTCCATGTCACATAGCCA CTTTCCATCTGCAAAGTCATCTATCTC
Figure 1
Survival for Gadd45aÀ/Àp53À/À and p53À/À mice. All mice developed tumors. Survival time is when mice were moribund, had obvious tumors or were found dead. Gadd45aÀ/Àp53À/À cohort is 20 males and three females; p53À/À cohort is 13 males and seven females. Gadd45a deletion may be a modifier locus for lymphomagenesis when other carcinogenic events are present. AKR mice harbor an endogenous retrovirus that leads to a high frequency of T-cell lymphoma and leukemia. Gadd45aÀ/À mice were crossed into the AKR background to determine if deletion could specifically affect lymphomagenesis in this model. As predicted, deletion of Gadd45a led to a decreased latency for lymphoma when compared with wt littermates (Figure 3 ). Mice that died of causes other than lymphoma are not included in Figure 3 , although it was presumed that most of these were likely due to leukemia. The LBL in Gadd45aÀ/Àp53À/À mice were similar to human LBL (also sometimes referred to as lymphoblastic T-NHL) in juvenile onset, immature T-cell phenotype and presentation with mediastinal masses. To investigate Gadd45a in human tumors, the four exons of Gadd45a were sequenced from 17 human LBL DNA samples, along with normal DNA from the same patients. 10 In all, 14 of these presented with mediastinal masses that are similar to the thymic masses seen in Gadd45aÀ/À p53À/À mice. No deletions, mutations or polymorphisms in the Gadd45a coding region or intron/exon boundaries were found in any of these samples. T-ALL is similar to LBL to the extent that differential diagnosis can be difficult. No deletions or mutations in Gadd45a were found in nine T-ALL and nine B-ALL samples (used for comparison).
At the cellular level, Gadd45aÀ/Àp53À/À mouse embryo fibroblasts (MEF) were similar in many respects to p53À/À MEF. Cell growth rate is markedly increased in p53À/À MEF and deletion of Gadd45a in this background has no additional effect even though Gadd45a deletion affects cell growth in the presence of wt p53 (data not shown and Hollander et al 2 ). In addition, Gadd45aÀ/À and p53À/À MEF had similar levels of aneuploidy, which was unaffected when both genes were deleted (data not shown).
Discussion
Many tumor suppressors and oncogenes, whose alteration is associated with lymphoma formation in humans and mice, transcriptionally regulate Gadd45a, either directly or indirectly. For example, deletion of p53 or ATM in mice, both of which transcriptionally activate Gadd45a, led to rapid spontaneous tumor formation including various types of lymphoma. 9, 11 Ataxia telangiectasia (AT) and Li Fraumeni syndrome, human syndromes in which ATM function is altered or where only a single copy of the p53 gene is present, are risk factors for lymphoma in humans. 12, 13 On the other hand, overexpression of c-myc, which downregulates Gadd45a, also led to lymphoma in mice.
14 Amplification of the c-myc gene, presumably also resulting in the downregulation of Gadd45a, is likely a causative factor in many human B-cell lymphomas. 15 Since many mouse lymphoma tumor models and associated human diseases have alteration of genes that affect Gadd45a transcription, non-or underexpression of Gadd45a may be an important factor in lymphomagenesis.
Although lymphoma is common in p53À/À mice, nearly all Gadd45aÀ/Àp53À/À mice developed lymphoma, most of which were classified as LBL. Young Gadd45aÀ/À mice have a nearly two-fold increase in thymic lymphoid cells, which may increase the tumor-prone target population upon subsequent p53 deletion. 2 Although hyperplasia often precedes tumorigenesis, only a slight increase in spontaneous lymphoma was observed in Gadd45aÀ/À mice (five of 21 Gadd45aÀ/À vs three of 21 wt mice mice at 17 months of age), none of which were classified as LBL. p27À/À mice exhibit thymus hyperplasia, and also do not develop lymphoma, but, like Gadd45aÀ/À, can synergize with other oncogenic stimuli to induce lymphoma (reviewed in Blain et al 16 ). In addition to increased thymus size, T cells from Gadd45aÀ/À mice have an increased in vitro proliferative response compared with those of wt mice, and this has been suggested to be a contributing cause of autoimmune disease in Gadd45aÀ/À mice. 17 Multiple types of human lymphoproliferative/autoimmune disease have been associated with increased incidence of lymphomas (reviewed in Ehrenfeld et al 18 ), and HTLVI infection can lead to both autoimmune disease and lymphoma. 19 Therefore, the presence of autoimmune disease in Gadd45aÀ/À mice may be a contributing factor to lymphomagenesis in the presence of additional tumor-promoting stimuli. Alternately, increased lymphoproliferation may contribute to both lymphomagenesis and autoimmune disease. It is proposed, therefore, that deletion Tumor types in Gadd45aÀ/Àp53À/À mice. Tumors are from the same mice as in Figure 1 . Lymphoma includes all subtypes, and sarcoma includes all subtypes. Thymic masses were determined at necropsy and filled most of the thoracic cavity.
Figure 3
Decreased survival of Gadd45aÀ/ÀAKR mice. All mice were littermates from AKR þ /ÀGadd45a þ /À crosses. The spleen, thymus and lymph nodes were taken from moribund mice or those found dead. Only mice with lymphoma in the spleen, thymus or lymph nodes are included (mice with nonlymphoma cause of death are censored, see Results). Wt AKR cohort was 21, Gadd45a þ /À/AKR was 47 and Gadd45aÀ/À/AKR was 23 mice, with similar number of males and females.
of Gadd45a is not sufficient for, but can contribute to lymphoma and is consequently a modifier locus for T-cell lymphomagenesis in mice.
Approximately 30% of childhood NHLs are classified as LBL. These are predominantly immature T cell in origin and, similar to the mice here, nearly 75% present with mediastinal masses. 20 Although T-ALL rarely presents with mediastinal masses, immature T cells are involved as in LBL. Owing to the high frequency of LBL in Gadd45aÀ/Àp53À/À mice, and the immature T-cell phenotype of tumor cells, the contribution of Gadd45a to these similar human neoplasms was investigated. 1p abnormalities have been reported in human T-cell neoplasms, and although 1p32 translocations involving the TAL1 gene are common in T-ALL, they are not in LBL. In fact, no specific gene alterations have been associated with LBL, and p53 mutations, which are frequent in many tumor types, have not been found. Owing to the proximity of Gadd45a, localized at 1p31.1-1p31.2, it was considered a candidate for alteration in T-cell tumors without TAL1 alteration. However, no Gadd45a mutations or deletions were found in biopsy samples from 17 LBL, nine T-ALL, or for comparison, nine B-ALL. Although Gadd45a RNA expression was not altered in T-or B-ALL (data not shown), LBL samples were not available for analysis. Since genes may also be inactivated in tumors by epigenetic mechanisms, Gadd45a expression should be investigated in this tumor type.
In conclusion, we have found that Gadd45a and p53 can act independently but cooperatively on tumorigenesis. In particular, thymic T-cell lymphomagenesis is amplified greatly in the Gadd45aÀ/Àp53À/À mice compared with p53À/À mice. Both Gadd45a and p53 are required for the maintenance of genome stability, while the additional roles of p53 in apoptosis and growth control may allow rapid tumorigenesis in mice lacking functional p53. The T-cell abnormalities conferred by deletion of Gadd45a leads to autoimmune disease in mice and, coupled with other oncogenic stimuli such as p53 deletion, endogenous retrovirus in AKR mice or IR, may be an etiological factor in T-cell lymphomagenesis as well.
